Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Pellegrini

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|December 24, 2009
Biochemical monitoring of the early endocytic traffic of the type I interferon receptorBéatrice Payelle-Brogard, Sandra Pellegrini
Gene|May 19, 2015
IFNA2: The prototypic human alpha interferonFranciane Paul, Sandra Pellegrini, Gilles Uzé
Plos One|December 15, 2010
T cell receptor signal initiation induced by low-grade stimulation requires the cooperation of LAT in human T cellsShen Dong, Béatrice Corre, Konstantina Nika, et al.
Molecular and Cellular Biology|July 1, 2009
Receptor density is key to the alpha2/beta interferon differential activitiesIgnacio Moraga, Daniel Harari, Gideon Schreiber, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 9, 2003
Down-modulation of responses to type I IFN upon T cell activationElisabetta Dondi, Lars Rogge, Georges Lutfalla, et al.
Journal of Leukocyte Biology|March 1, 2017
Type I interferon-enhanced IL-10 expression in human CD4 T cells is regulated by STAT3, STAT2, and BATF transcription factorsUmeshree Govender, Béatrice Corre, Yasmine Bourdache, et al.
Plos One|January 22, 2020
Two common disease-associated TYK2 variants impact exon splicing and TYK2 dosageZhi Li, Maxime Rotival, Etienne Patin, et al.
The Journal of Biological Chemistry|May 6, 2008
The Stat3-activating Tyk2 V678F mutant does not up-regulate signaling through the type I interferon receptor but confers ligand hypersensitivity to a homodimeric receptorMilica Gakovic, Josiane Ragimbeau, Véronique Francois, et al.
The Biochemical Journal|July 14, 2007
Comparable potency of IFNalpha2 and IFNbeta on immediate JAK/STAT activation but differential down-regulation of IFNAR2Zrinka Marijanovic, Josiane Ragimbeau, José van der Heyden, et al.
The Biochemical Journal|June 27, 2012
USP18 establishes the transcriptional and anti-proliferative interferon α/β differentialVéronique Francois-Newton, Mark Livingstone, Béatrice Payelle-Brogard, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|December 24, 2009
Biochemical monitoring of the early endocytic traffic of the type I interferon receptorBéatrice Payelle-Brogard, Sandra Pellegrini
Gene|May 19, 2015
IFNA2: The prototypic human alpha interferonFranciane Paul, Sandra Pellegrini, Gilles Uzé
Plos One|December 15, 2010
T cell receptor signal initiation induced by low-grade stimulation requires the cooperation of LAT in human T cellsShen Dong, Béatrice Corre, Konstantina Nika, et al.
Molecular and Cellular Biology|July 1, 2009
Receptor density is key to the alpha2/beta interferon differential activitiesIgnacio Moraga, Daniel Harari, Gideon Schreiber, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 9, 2003
Down-modulation of responses to type I IFN upon T cell activationElisabetta Dondi, Lars Rogge, Georges Lutfalla, et al.
Journal of Leukocyte Biology|March 1, 2017
Type I interferon-enhanced IL-10 expression in human CD4 T cells is regulated by STAT3, STAT2, and BATF transcription factorsUmeshree Govender, Béatrice Corre, Yasmine Bourdache, et al.
Plos One|January 22, 2020
Two common disease-associated TYK2 variants impact exon splicing and TYK2 dosageZhi Li, Maxime Rotival, Etienne Patin, et al.
The Journal of Biological Chemistry|May 6, 2008
The Stat3-activating Tyk2 V678F mutant does not up-regulate signaling through the type I interferon receptor but confers ligand hypersensitivity to a homodimeric receptorMilica Gakovic, Josiane Ragimbeau, Véronique Francois, et al.
The Biochemical Journal|July 14, 2007
Comparable potency of IFNalpha2 and IFNbeta on immediate JAK/STAT activation but differential down-regulation of IFNAR2Zrinka Marijanovic, Josiane Ragimbeau, José van der Heyden, et al.
The Biochemical Journal|June 27, 2012
USP18 establishes the transcriptional and anti-proliferative interferon α/β differentialVéronique Francois-Newton, Mark Livingstone, Béatrice Payelle-Brogard, et al.
Pageof 6